Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Synopsis
Increasing prevalence of cancer, increasing preference for noninvasive procedures, and availability of funding for liquid biopsy R&D are some of the key factors driving the growth of the market.
The global Liquid Biopsy market was valued at US$ 823.9 million in 2023 and is anticipated to reach US$ 2822.9 million by 2030, witnessing a CAGR of 18.7% during the forecast period 2024-2030.
The non-cancer application segment is expected to be the fastest-growing segment in the market during the forecast period.
This report aims to provide a comprehensive presentation of the global market for Liquid Biopsy, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Liquid Biopsy.
Report Scope
The Liquid Biopsy market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Liquid Biopsy market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Liquid Biopsy manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company(Partial List)
Segment by Type
Segment by Application
Consumption by Region
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Liquid Biopsy manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Liquid Biopsy in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index
1 Liquid Biopsy Market Overview
1.1 Product Overview and Scope of Liquid Biopsy
1.2 Liquid Biopsy Segment by Type
1.2.1 Global Liquid Biopsy Market Value Comparison by Type (2024-2030)
1.2.2 Test Suite
1.2.3 Equipment
1.2.4 Service
1.3 Liquid Biopsy Segment by Application
1.3.1 Global Liquid Biopsy Market Value by Application: (2024-2030)
1.3.2 Food Laboratory
1.3.3 The Hospital
1.3.4 Research Center
1.3.5 Other
1.4 Global Liquid Biopsy Market Size Estimates and Forecasts
1.4.1 Global Liquid Biopsy Revenue 2019-2030
1.4.2 Global Liquid Biopsy Sales 2019-2030
1.4.3 Global Liquid Biopsy Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Liquid Biopsy Market Competition by Manufacturers
2.1 Global Liquid Biopsy Sales Market Share by Manufacturers (2019-2024)
2.2 Global Liquid Biopsy Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Liquid Biopsy Average Price by Manufacturers (2019-2024)
2.4 Global Liquid Biopsy Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Liquid Biopsy, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Liquid Biopsy, Product Type & Application
2.7 Liquid Biopsy Market Competitive Situation and Trends
2.7.1 Liquid Biopsy Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Liquid Biopsy Players Market Share by Revenue
2.7.3 Global Liquid Biopsy Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Liquid Biopsy Retrospective Market Scenario by Region
3.1 Global Liquid Biopsy Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Liquid Biopsy Global Liquid Biopsy Sales by Region: 2019-2030
3.2.1 Global Liquid Biopsy Sales by Region: 2019-2024
3.2.2 Global Liquid Biopsy Sales by Region: 2025-2030
3.3 Global Liquid Biopsy Global Liquid Biopsy Revenue by Region: 2019-2030
3.3.1 Global Liquid Biopsy Revenue by Region: 2019-2024
3.3.2 Global Liquid Biopsy Revenue by Region: 2025-2030
3.4 North America Liquid Biopsy Market Facts & Figures by Country
3.4.1 North America Liquid Biopsy Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Liquid Biopsy Sales by Country (2019-2030)
3.4.3 North America Liquid Biopsy Revenue by Country (2019-2030)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Liquid Biopsy Market Facts & Figures by Country
3.5.1 Europe Liquid Biopsy Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Liquid Biopsy Sales by Country (2019-2030)
3.5.3 Europe Liquid Biopsy Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Liquid Biopsy Market Facts & Figures by Country
3.6.1 Asia Pacific Liquid Biopsy Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Liquid Biopsy Sales by Country (2019-2030)
3.6.3 Asia Pacific Liquid Biopsy Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Liquid Biopsy Market Facts & Figures by Country
3.7.1 Latin America Liquid Biopsy Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Liquid Biopsy Sales by Country (2019-2030)
3.7.3 Latin America Liquid Biopsy Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Liquid Biopsy Market Facts & Figures by Country
3.8.1 Middle East and Africa Liquid Biopsy Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Liquid Biopsy Sales by Country (2019-2030)
3.8.3 Middle East and Africa Liquid Biopsy Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Liquid Biopsy Sales by Type (2019-2030)
4.1.1 Global Liquid Biopsy Sales by Type (2019-2024)
4.1.2 Global Liquid Biopsy Sales by Type (2025-2030)
4.1.3 Global Liquid Biopsy Sales Market Share by Type (2019-2030)
4.2 Global Liquid Biopsy Revenue by Type (2019-2030)
4.2.1 Global Liquid Biopsy Revenue by Type (2019-2024)
4.2.2 Global Liquid Biopsy Revenue by Type (2025-2030)
4.2.3 Global Liquid Biopsy Revenue Market Share by Type (2019-2030)
4.3 Global Liquid Biopsy Price by Type (2019-2030)
5 Segment by Application
5.1 Global Liquid Biopsy Sales by Application (2019-2030)
5.1.1 Global Liquid Biopsy Sales by Application (2019-2024)
5.1.2 Global Liquid Biopsy Sales by Application (2025-2030)
5.1.3 Global Liquid Biopsy Sales Market Share by Application (2019-2030)
5.2 Global Liquid Biopsy Revenue by Application (2019-2030)
5.2.1 Global Liquid Biopsy Revenue by Application (2019-2024)
5.2.2 Global Liquid Biopsy Revenue by Application (2025-2030)
5.2.3 Global Liquid Biopsy Revenue Market Share by Application (2019-2030)
5.3 Global Liquid Biopsy Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Biocept
6.1.1 Biocept Corporation Information
6.1.2 Biocept Description and Business Overview
6.1.3 Biocept Liquid Biopsy Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Biocept Liquid Biopsy Product Portfolio
6.1.5 Biocept Recent Developments/Updates
6.2 Qiagen
6.2.1 Qiagen Corporation Information
6.2.2 Qiagen Description and Business Overview
6.2.3 Qiagen Liquid Biopsy Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Qiagen Liquid Biopsy Product Portfolio
6.2.5 Qiagen Recent Developments/Updates
6.3 Roche Diagnostics
6.3.1 Roche Diagnostics Corporation Information
6.3.2 Roche Diagnostics Description and Business Overview
6.3.3 Roche Diagnostics Liquid Biopsy Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Roche Diagnostics Liquid Biopsy Product Portfolio
6.3.5 Roche Diagnostics Recent Developments/Updates
6.4 Bio-Rad Laboratories
6.4.1 Bio-Rad Laboratories Corporation Information
6.4.2 Bio-Rad Laboratories Description and Business Overview
6.4.3 Bio-Rad Laboratories Liquid Biopsy Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Bio-Rad Laboratories Liquid Biopsy Product Portfolio
6.4.5 Bio-Rad Laboratories Recent Developments/Updates
6.5 Myriad Genetics
6.5.1 Myriad Genetics Corporation Information
6.5.2 Myriad Genetics Description and Business Overview
6.5.3 Myriad Genetics Liquid Biopsy Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Myriad Genetics Liquid Biopsy Product Portfolio
6.5.5 Myriad Genetics Recent Developments/Updates
6.6 Menarini-Silicon Biosystems
6.6.1 Menarini-Silicon Biosystems Corporation Information
6.6.2 Menarini-Silicon Biosystems Description and Business Overview
6.6.3 Menarini-Silicon Biosystems Liquid Biopsy Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Menarini-Silicon Biosystems Liquid Biopsy Product Portfolio
6.6.5 Menarini-Silicon Biosystems Recent Developments/Updates
6.7 Trovagene
6.6.1 Trovagene Corporation Information
6.6.2 Trovagene Description and Business Overview
6.6.3 Trovagene Liquid Biopsy Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Trovagene Liquid Biopsy Product Portfolio
6.7.5 Trovagene Recent Developments/Updates
6.8 Guardant Health
6.8.1 Guardant Health Corporation Information
6.8.2 Guardant Health Description and Business Overview
6.8.3 Guardant Health Liquid Biopsy Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Guardant Health Liquid Biopsy Product Portfolio
6.8.5 Guardant Health Recent Developments/Updates
6.9 Mdxhealth
6.9.1 Mdxhealth Corporation Information
6.9.2 Mdxhealth Description and Business Overview
6.9.3 Mdxhealth Liquid Biopsy Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Mdxhealth Liquid Biopsy Product Portfolio
6.9.5 Mdxhealth Recent Developments/Updates
6.10 Genomic Health
6.10.1 Genomic Health Corporation Information
6.10.2 Genomic Health Description and Business Overview
6.10.3 Genomic Health Liquid Biopsy Sales, Revenue and Gross Margin (2019-2024)
6.10.4 Genomic Health Liquid Biopsy Product Portfolio
6.10.5 Genomic Health Recent Developments/Updates
6.11 Raindance Technologies
6.11.1 Raindance Technologies Corporation Information
6.11.2 Raindance Technologies Liquid Biopsy Description and Business Overview
6.11.3 Raindance Technologies Liquid Biopsy Sales, Revenue and Gross Margin (2019-2024)
6.11.4 Raindance Technologies Liquid Biopsy Product Portfolio
6.11.5 Raindance Technologies Recent Developments/Updates
6.12 Thermo Fisher Scientific
6.12.1 Thermo Fisher Scientific Corporation Information
6.12.2 Thermo Fisher Scientific Liquid Biopsy Description and Business Overview
6.12.3 Thermo Fisher Scientific Liquid Biopsy Sales, Revenue and Gross Margin (2019-2024)
6.12.4 Thermo Fisher Scientific Liquid Biopsy Product Portfolio
6.12.5 Thermo Fisher Scientific Recent Developments/Updates
6.13 Illumina
6.13.1 Illumina Corporation Information
6.13.2 Illumina Liquid Biopsy Description and Business Overview
6.13.3 Illumina Liquid Biopsy Sales, Revenue and Gross Margin (2019-2024)
6.13.4 Illumina Liquid Biopsy Product Portfolio
6.13.5 Illumina Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Liquid Biopsy Industry Chain Analysis
7.2 Liquid Biopsy Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Liquid Biopsy Production Mode & Process
7.4 Liquid Biopsy Sales and Marketing
7.4.1 Liquid Biopsy Sales Channels
7.4.2 Liquid Biopsy Distributors
7.5 Liquid Biopsy Customers
8 Liquid Biopsy Market Dynamics
8.1 Liquid Biopsy Industry Trends
8.2 Liquid Biopsy Market Drivers
8.3 Liquid Biopsy Market Challenges
8.4 Liquid Biopsy Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
Published By : QY Research